Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
| Image |  |
|---|---|
| Description | scientific article published on 25 August 2020 |
| Author/s |
author: David A Fraser John J. P. Kastelein |
| Publication date | August 25, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |